Drug substitution in transplantation: A National Kidney Foundation white paper
- 1 February 1999
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 33 (2) , 389-397
- https://doi.org/10.1016/s0272-6386(99)70318-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- What are narrow therapeutic index drugs?Clinical Pharmacology & Therapeutics, 1998
- LACK OF BIOEQUIVALENCE OF TWO SANDIMMUNE® CYCLOSPORINE FORMULATIONS IN RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLYTransplantation, 1998
- Generic SubstitutionJAMA, 1998
- Simple Bioequivalence CriteriaTherapeutic Drug Monitoring, 1997
- FDA position on product selection for ‘narrow therapeutic index’ drugsAmerican Journal of Health-System Pharmacy, 1997
- Bioequivalence and Generic Prescribing: An Industrial ViewJournal of Pharmacy and Pharmacology, 1996
- GENERIC BIOEQUIVALENCEJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- Effects of Food on the Bioequivalence of Different Verapamil Sustained‐Release FormulationsThe Journal of Clinical Pharmacology, 1995
- Bioinequivalence and Drug ToxicityDrug Safety, 1994
- Generic Drug Substitution RevisitedNew England Journal of Medicine, 1987